Inflammation appears to play a critical role in the formation of cerebral aneurysms, their progression to rupture- prone type, and ultimately to rupture. Evidence supporting this hypothesis includes recent data from human neurosurgery patients and experimental animal models demonstrating that aneurysm wall tissue is rich with macrophages and inflammatory molecules. To investigate potential therapeutic implications of this hypothesis, I carried out a retrospective study examining whether patients with ruptured cerebral aneurysms who took aspirin had a reduced risk of aneurysm rupture. This study was performed using the International Study of Unruptured Intracranial Aneurysms data base. Patients who used aspirin three times weekly to daily have a significantly decreased risk of aneurysm rupture. My current scientific goals, and the subject of this proposal, are to study the molecular mechanisms by which inflammation influences cerebral aneurysm formation and rupture. I am using the well-established Hashimoto mouse aneurysm model to pursue two specific aims.
In Specific Aim 1, I will determine the contributions of COX-1 and COX-2 to the protective effect of aspirin against aneurysm rupture.
In Specific Aim 2, I will determine the cell type associated with activation of the COX-2 pathway resulting in a protective effect against aneurysm rupture. These studies will involve the use of complementary genetic, pharmacological and bone marrow transplantation experimental approaches. Knowledge of the inflammation related molecular mechanisms of aneurysm formation and rupture will provide information that is critical to the development of effective new medical therapies for patients wit this dangerous cerebrovascular disease.
The primary goal of the proposed project is to delineate molecular mechanisms of the protective effect of aspirin in reducing the incidence of cerebral aneurysm rupture using an experimental animal model.
|Hasan, David M; Bayman, Emine; Broderick, Joseph (2017) Letter by Hasan et al Regarding Article, ""Aspirin and Risk of Subarachnoid Hemorrhage: Systematic Review and Meta-Analysis"". Stroke 48:e184-e185|
|Chalouhi, Nohra; Starke, Robert M; Correa, Tatiana et al. (2016) Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice. Hypertension 68:411-7|
|Starke, Robert M; Chalouhi, Nohra; Ding, Dale et al. (2015) Potential role of aspirin in the prevention of aneurysmal subarachnoid hemorrhage. Cerebrovasc Dis 39:332-42|
|Peña-Silva, Ricardo A; Chalouhi, Nohra; Wegman-Points, Lauren et al. (2015) Novel role for endogenous hepatocyte growth factor in the pathogenesis of intracranial aneurysms. Hypertension 65:587-93|
|Chu, Yi; Wilson, Katina; Gu, He et al. (2015) Myeloperoxidase is increased in human cerebral aneurysms and increases formation and rupture of cerebral aneurysms in mice. Stroke 46:1651-6|
|Peña Silva, Ricardo A; Mitchell, Ian J; Kung, David K et al. (2015) Paradoxical Increase in Mortality and Rupture of Intracranial Aneurysms in Microsomal Prostaglandin E2 Synthase Type 1-Deficient Mice: Attenuation by Aspirin. Neurosurgery 77:613-20|
|Hoppe, Anna L; Raghavan, Madhavan L; Hasan, David M (2015) Comparison of the association of sac growth and coil compaction with recurrence in coil embolized cerebral aneurysms. PLoS One 10:e0123017|
|Hasan, David M; Starke, Robert M; Gu, He et al. (2015) Smooth Muscle Peroxisome Proliferator-Activated Receptor ? Plays a Critical Role in Formation and Rupture of Cerebral Aneurysms in Mice In Vivo. Hypertension 66:211-20|
|Hasan, David M; Hindman, Bradley J; Todd, Michael M (2015) Pressure changes within the sac of human cerebral aneurysms in response to artificially induced transient increases in systemic blood pressure. Hypertension 66:324-31|
|Peña Silva, Ricardo A; Kung, David K; Mitchell, Ian J et al. (2014) Angiotensin 1-7 reduces mortality and rupture of intracranial aneurysms in mice. Hypertension 64:362-8|
Showing the most recent 10 out of 15 publications